{"nct_id":"NCT04462198","title":"Phase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing Loss","status":"COMPLETED","status_verified_date":"2020-10","start_date":"2020-10-15","start_date_type":"ACTUAL","primary_completion_date":"2021-06-17","primary_completion_date_type":"ACTUAL","completion_date":"2021-06-17","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["CTNM"]}